Globus Medical (NYSE: GMED) reported Q3 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $169.2 million versus the consensus estimate of $167.54 million.

GUIDANCE:

Globus Medical sees FY2018 EPS of $1.62, versus the consensus of $1.55. Globus Medical sees FY2018 revenue of $705 million, versus the consensus of $701.4 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.